WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Broker-Dealer
  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Investment Adviser
  • Israel
  • Latin America
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • Decarbonization Strategies
  • Energy Regulation and Competition
  • Project Development and Transactions
  • Project Finance and Tax Equity
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • National Security
  • Payments
  • Privacy and Cybersecurity
  • Strategic Risk and Crisis Management

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Merger Clearance
  • Antitrust Litigation
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • FoodTech and AgTech
  • Fintech and Financial Services
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Semiconductors
  • Software

  • Offices
  • Events
  • Pro Bono
  • Community
  • Our Diversity
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Beijing
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • SOMA
  • Washington, D.C.
  • Wilmington, DE

  • Law Students + Recent Graduates
  • Experienced Attorneys
  • Patent Agents
  • Professional Staff
  • Alternative Legal Careers
  • Contact Recruiting
Michael T. Rosato
Partner
Litigation
Seattle
mrosato@wsgr.com

D206-883-2529

Download vCard
Open PDF
  • A Practice Leader

    Michael leads the firm’s practice involving contested proceedings at the USPTO and has extensive experience representing clients before the Patent Trial and Appeal Board, including USPTO proceedings under the America Invents Act.

  • Extensive PTAB Experience

    He has served as lead counsel in numerous inter partes review and covered business method review proceedings, patent interferences, and reexamination procedures, as well as corresponding appeals to the CAFC.

  • A Leading Patent Practitioner

    Michael has been ranked by Docket Navigator as the No. 1 attorney for representing litigants in inter partes, CBM, or post-grant review proceedings at the PTAB; honored by Managing Intellectual Property for filing the most petitions on behalf of petitioners; named the 2022 Post-Grant Proceedings Attorney of the Year by LMG Life Sciences; recognized by Patexia as one of the most active practitioners for inter partes review proceedings; and recognized by Intellectual Asset Management and Washington Super Lawyers as a leader in his field.

Michael Rosato is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where he focuses on intellectual property protection and counseling, as well as intellectual property-related disputes. Michael leads the firm's practice involving contested proceedings at the U.S. Patent and Trademark Office. He has extensive experience representing clients before the Patent Trial and Appeal Board (formerly the Board of Patent Appeals and Interferences), including USPTO proceedings under the America Invents Act (AIA). Michael has served as lead counsel in numerous inter partes review (IPR) and covered business method (CBM) review proceedings, patent interferences, and reexamination procedures, as well as corresponding appeals to the Court of Appeals for the Federal Circuit (CAFC). He has significant experience with international and domestic patent protection and enforcement for both early- and later-stage companies, often involving a combination of mechanical technologies, software systems and electronics, and medical sciences or biotechnology.

Prior to joining the firm, Michael was an intellectual property partner in the Seattle office of Kilpatrick Townsend & Stockton (formerly Townsend and Townsend and Crew). He began his legal career at DLA Piper and previously worked as a patent agent for a microfluidics device manufacturer.

Experience

Michael Rosato is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where he focuses on intellectual property protection and counseling, as well as intellectual property-related disputes. Michael leads the firm's practice involving contested proceedings at the U.S. Patent and Trademark Office. He has extensive experience representing clients before the Patent Trial and Appeal Board (formerly the Board of Patent Appeals and Interferences), including USPTO proceedings under the America Invents Act (AIA). Michael has served as lead counsel in numerous inter partes review (IPR) and covered business method (CBM) review proceedings, patent interferences, and reexamination procedures, as well as corresponding appeals to the Court of Appeals for the Federal Circuit (CAFC). He has significant experience with international and domestic patent protection and enforcement for both early- and later-stage companies, often involving a combination of mechanical technologies, software systems and electronics, and medical sciences or biotechnology.

Prior to joining the firm, Michael was an intellectual property partner in the Seattle office of Kilpatrick Townsend & Stockton (formerly Townsend and Townsend and Crew). He began his legal career at DLA Piper and previously worked as a patent agent for a microfluidics device manufacturer.

Education
  • J.D., University of Washington School of Law, 2002
  • M.S., University of Washington, 1999
  • B.S., Rutgers University, 1996George H. Cook Scholar
Honors
  • Named as the Post-Grant Proceedings Attorney of the Year by the LMG Life Sciences 2022 America Awards

  • Recognized by Patexia as one of the most active practitioners for inter partes review proceedings

  • Recognized by Docket Navigator as the No. 1 attorney for representing litigants in 2016 inter partes review, covered business method, or post-grant review proceedings at the PTAB
  • Recognized by Managing Intellectual Property as the No. 1 attorney in the U.S. for filing the most petitions on behalf of petitioners in the first half of 2016
  • Recognized in the 2013-2016 and 2022-2023 editions of Intellectual Asset Management (IAM) magazine's IAM Patent 1000 - World's Leading Patent Practitioners guide
  • Named to Washington Super Lawyers' list of "Rising Stars" in 2007, 2008, 2010, 2011, and 2012
Admissions
  • State Bar of Washington
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of Washington School of Law, 2002
  • M.S., University of Washington, 1999
  • B.S., Rutgers University, 1996George H. Cook Scholar
Honors
  • Named as the Post-Grant Proceedings Attorney of the Year by the LMG Life Sciences 2022 America Awards

  • Recognized by Patexia as one of the most active practitioners for inter partes review proceedings

  • Recognized by Docket Navigator as the No. 1 attorney for representing litigants in 2016 inter partes review, covered business method, or post-grant review proceedings at the PTAB
  • Recognized by Managing Intellectual Property as the No. 1 attorney in the U.S. for filing the most petitions on behalf of petitioners in the first half of 2016
  • Recognized in the 2013-2016 and 2022-2023 editions of Intellectual Asset Management (IAM) magazine's IAM Patent 1000 - World's Leading Patent Practitioners guide
  • Named to Washington Super Lawyers' list of "Rising Stars" in 2007, 2008, 2010, 2011, and 2012
Admissions
  • State Bar of Washington
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Patent and Trademark Office

Select Matters

  • Medtronic, Inc. v. NuVasive, Inc.* (IPR and Reexamination Reviews, CAFC Appeals)
  • Bungie, Inc.* v. Worlds Inc. (IPR Reviews, CAFC Appeals)
  • Altaire Pharmaceuticals, Inc. v. Paragon BioTek, Inc.* (PGR Review, CAFC Appeal)
  • Minerva Surgical, Inc.* v. Hologic, Inc. (IPR and PGR Reviews)
  • ClearCorrect Operating, LLC v. Align Technology, Inc.* (IPR, Reexamination Reviews)
  • Fitbit,Inc. v. AliphCom, Inc. d/b/a Jawbone* (IPR Reviews)
  • Interactive Brokers LLC et al.* v. Chart Trading Development LLC. (CBM Reviews)
  • Blue Coat Systems, Inc.* v. Finjan, Inc. (IPR Reviews)
  • Bloomberg Inc. et al.* v. Markets Alert Pty Ltd (CBM Review)
  • Salesforce.com, Inc.* v. VirtualAgility, Inc. (CBM Reviews)
  • Trulia, Inc.* v. Zillow, Inc. (CBM Reviews)
  • Voltage Security, Inc.* v. Protegrity Corporation (CBM Review)
  • E*TRADE Financial Corporation et al. * v. Droplets, Inc. (IPR Reviews and CAFC Appeal)
  • Hughes Communications, Inc. v. California Institute of Technology (Caltech)* (IPR Reviews)
  • GTNX, Inc.* v. INTTRA, INC. (CBM Reviews)
  • Square, Inc.* v. Think Computer Corporation (CBM Review and CAFC Appeal)
  • Square, Inc.* v. Protegrity Corporation (CBM Reviews)
  • Google Inc.* and LinkedIn Corporation* v. Priceplay.com, Inc. (CBM Reviews)
  • Harmonic, Inc.* v. Avid Technology, Inc. (IPR and Reexamination Reviews)
  • Ariosa Diagnostics v. Verinata Health, Inc. (Illumina Corp.)* (IPR Reviews and CAFC Appeal)
  • Universal Display Corp.* v. Fujifilm, Inc. (Patent Interference)
  • Alnylam Pharmaceuticals, Inc. v. Protiva Biotherapeutics, Inc. (Tekmira Corp.)* (Patent Interference)
  • Genentech, Inc. v. Dendreon Corp.* (Patent Interference)
  • Zymogenetics, Inc.* v. Genentech, Inc. (Patent Interference)

*Party Represented

Matters

Select Matters

  • Medtronic, Inc. v. NuVasive, Inc.* (IPR and Reexamination Reviews, CAFC Appeals)
  • Bungie, Inc.* v. Worlds Inc. (IPR Reviews, CAFC Appeals)
  • Altaire Pharmaceuticals, Inc. v. Paragon BioTek, Inc.* (PGR Review, CAFC Appeal)
  • Minerva Surgical, Inc.* v. Hologic, Inc. (IPR and PGR Reviews)
  • ClearCorrect Operating, LLC v. Align Technology, Inc.* (IPR, Reexamination Reviews)
  • Fitbit,Inc. v. AliphCom, Inc. d/b/a Jawbone* (IPR Reviews)
  • Interactive Brokers LLC et al.* v. Chart Trading Development LLC. (CBM Reviews)
  • Blue Coat Systems, Inc.* v. Finjan, Inc. (IPR Reviews)
  • Bloomberg Inc. et al.* v. Markets Alert Pty Ltd (CBM Review)
  • Salesforce.com, Inc.* v. VirtualAgility, Inc. (CBM Reviews)
  • Trulia, Inc.* v. Zillow, Inc. (CBM Reviews)
  • Voltage Security, Inc.* v. Protegrity Corporation (CBM Review)
  • E*TRADE Financial Corporation et al. * v. Droplets, Inc. (IPR Reviews and CAFC Appeal)
  • Hughes Communications, Inc. v. California Institute of Technology (Caltech)* (IPR Reviews)
  • GTNX, Inc.* v. INTTRA, INC. (CBM Reviews)
  • Square, Inc.* v. Think Computer Corporation (CBM Review and CAFC Appeal)
  • Square, Inc.* v. Protegrity Corporation (CBM Reviews)
  • Google Inc.* and LinkedIn Corporation* v. Priceplay.com, Inc. (CBM Reviews)
  • Harmonic, Inc.* v. Avid Technology, Inc. (IPR and Reexamination Reviews)
  • Ariosa Diagnostics v. Verinata Health, Inc. (Illumina Corp.)* (IPR Reviews and CAFC Appeal)
  • Universal Display Corp.* v. Fujifilm, Inc. (Patent Interference)
  • Alnylam Pharmaceuticals, Inc. v. Protiva Biotherapeutics, Inc. (Tekmira Corp.)* (Patent Interference)
  • Genentech, Inc. v. Dendreon Corp.* (Patent Interference)
  • Zymogenetics, Inc.* v. Genentech, Inc. (Patent Interference)

*Party Represented

Select Publications

  • Co-author, "How 'Rocket Dockets' Are Affecting IPR Discretionary Denials," Law360, November 24, 2021
  • Co-author, The PTAB Review, June 2017
  • Co-author, 2016 PTAB Year in Review, January 2017
  • Co-author, "Federal Circuit Limits Petitioner Appeal Rights from the Patent Trial and Appeal Board for Inter Partes Reviews," WSGR Alert, January 11, 2017
  • Co-author, The PTAB Review, November 2016
  • Co-author, The PTAB Review, August 2016
  • Co-author, "U.S. Supreme Court Decides Cuozzo v. Lee: Upholds General Bar Against Appealing PTAB's Institution Decisions and Affirms Use of "Broadest Reasonable Interpretation" Standard for Claim Construction," WSGR Alert, June 20, 2016
  • Co-author, The PTAB Review, June 2016
  • Co-author, The PTAB Review, April 2016
  • Co-author, "USPTO Issues Second Round of AIA Rule Changes," WSGR Alert, April 1, 2016
  • Co-author, "Federal Circuit Ruling in Dell v. Acceleron Limits New Late-Stage Grounds of Challenge in America Invents Act Trials," WSGR Alert, March 15, 2016
  • Co-author, "USPTO Announces Second Round of AIA Rule Changes," WSGR Alert, August 21, 2015
  • Co-author, "Federal Circuit Allows Judicial Review of PTAB's Determination That Patent Qualifies as 'Covered Business Method,'" WSGR Alert, July 9, 2015
  • Co-author, "A Divided Federal Circuit Confirms Broadest Reasonable Interpretation for Claims in Inter Partes Review on Rehearing," WSGR Alert, July 8, 2015
  • Co-author, "USPTO Announces Significant Reforms in Three Rounds of AIA Rule Changes—Round One: Increased Page Limits for Motions to Amend and Reply Briefs," WSGR Alert, March 30, 2015
  • Co-author, "Federal Circuit Decides Appeal from First Final PTAB Decision in Inter Partes Review," WSGR Alert, February 4, 2015


Recent Speaking Engagements

  • Moderator, "A 360 Review of the Current Status of IPR Practice," American Intellectual Property Law Association 2017 Spring Meeting, San Diego, California, May 2017
  • Panelist, "Inter Partes Review and the Increasing Role of the PTAB in Invalidity Litigation," USC Gould School of Law 2017 Intellectual Property Institute, Santa Monica, California, March 2017
  • Panelist, "Evidence of Prior Art at the PTAB: Rigorous Proof—or Else," IPO IP Chat Channel webinar, January 2017
  • Presenter, "PTAB Proceedings: New Rules and Key Practice Tips," UT Law's 2016 Advanced Patent Law Institute, Austin, Texas, November 2016
  • Faculty Speaker, "The Other Worlds: Covered Business Method (CBM) Challenges & Post-Grant Review," Practising Law Institute's USPTO Post-Grant Patent Trials 2016 webinar, April 5, 2016
  • Presenter, "Patent Trial and Appeal Board (PTAB) Developments and Trial Strategy," IP Defense Summit – Seattle, October 2015
  • Presenter, "Post-Grant Patent Trials 'Lessons Learned': Post Institution & Hearing," UT-Law: Advanced Patent Law Institute, Austin, Texas, November 2014
  • Panelist, "Strategies for Forum Selection (District Courts v. ITC v. USPTO/PTAB)," The Sedona Conference All Voices Meeting 2014, New Orleans, Louisiana, November 2014
  • Presenting Practitioner, "PTAB AIA Trial Roundtables," USPTO Roadshow, Santa Clara, California, April 2014
  • Faculty Speaker, "Covered Business Method (CBM) Challenges and Post-Grant Review (PGR)," USPTO Post-Grant Patent Trials 2014, Practicing Law Institute, San Francisco, California, April 2014
Insights

Select Publications

  • Co-author, "How 'Rocket Dockets' Are Affecting IPR Discretionary Denials," Law360, November 24, 2021
  • Co-author, The PTAB Review, June 2017
  • Co-author, 2016 PTAB Year in Review, January 2017
  • Co-author, "Federal Circuit Limits Petitioner Appeal Rights from the Patent Trial and Appeal Board for Inter Partes Reviews," WSGR Alert, January 11, 2017
  • Co-author, The PTAB Review, November 2016
  • Co-author, The PTAB Review, August 2016
  • Co-author, "U.S. Supreme Court Decides Cuozzo v. Lee: Upholds General Bar Against Appealing PTAB's Institution Decisions and Affirms Use of "Broadest Reasonable Interpretation" Standard for Claim Construction," WSGR Alert, June 20, 2016
  • Co-author, The PTAB Review, June 2016
  • Co-author, The PTAB Review, April 2016
  • Co-author, "USPTO Issues Second Round of AIA Rule Changes," WSGR Alert, April 1, 2016
  • Co-author, "Federal Circuit Ruling in Dell v. Acceleron Limits New Late-Stage Grounds of Challenge in America Invents Act Trials," WSGR Alert, March 15, 2016
  • Co-author, "USPTO Announces Second Round of AIA Rule Changes," WSGR Alert, August 21, 2015
  • Co-author, "Federal Circuit Allows Judicial Review of PTAB's Determination That Patent Qualifies as 'Covered Business Method,'" WSGR Alert, July 9, 2015
  • Co-author, "A Divided Federal Circuit Confirms Broadest Reasonable Interpretation for Claims in Inter Partes Review on Rehearing," WSGR Alert, July 8, 2015
  • Co-author, "USPTO Announces Significant Reforms in Three Rounds of AIA Rule Changes—Round One: Increased Page Limits for Motions to Amend and Reply Briefs," WSGR Alert, March 30, 2015
  • Co-author, "Federal Circuit Decides Appeal from First Final PTAB Decision in Inter Partes Review," WSGR Alert, February 4, 2015


Recent Speaking Engagements

  • Moderator, "A 360 Review of the Current Status of IPR Practice," American Intellectual Property Law Association 2017 Spring Meeting, San Diego, California, May 2017
  • Panelist, "Inter Partes Review and the Increasing Role of the PTAB in Invalidity Litigation," USC Gould School of Law 2017 Intellectual Property Institute, Santa Monica, California, March 2017
  • Panelist, "Evidence of Prior Art at the PTAB: Rigorous Proof—or Else," IPO IP Chat Channel webinar, January 2017
  • Presenter, "PTAB Proceedings: New Rules and Key Practice Tips," UT Law's 2016 Advanced Patent Law Institute, Austin, Texas, November 2016
  • Faculty Speaker, "The Other Worlds: Covered Business Method (CBM) Challenges & Post-Grant Review," Practising Law Institute's USPTO Post-Grant Patent Trials 2016 webinar, April 5, 2016
  • Presenter, "Patent Trial and Appeal Board (PTAB) Developments and Trial Strategy," IP Defense Summit – Seattle, October 2015
  • Presenter, "Post-Grant Patent Trials 'Lessons Learned': Post Institution & Hearing," UT-Law: Advanced Patent Law Institute, Austin, Texas, November 2014
  • Panelist, "Strategies for Forum Selection (District Courts v. ITC v. USPTO/PTAB)," The Sedona Conference All Voices Meeting 2014, New Orleans, Louisiana, November 2014
  • Presenting Practitioner, "PTAB AIA Trial Roundtables," USPTO Roadshow, Santa Clara, California, April 2014
  • Faculty Speaker, "Covered Business Method (CBM) Challenges and Post-Grant Review (PGR)," USPTO Post-Grant Patent Trials 2014, Practicing Law Institute, San Francisco, California, April 2014
Focus Areas
  • Intellectual Property
  • Life Sciences
  • Litigation
  • Patent Litigation
  • Patents and Innovations
  • Post-Grant Review
  • Supreme Court and Appellate
Recent Insights
News Articles
Wilson Sonsini Attorneys Recognized in 2023 IAM Patent 1000
IAM Patent 1000 has recognized Wilson Sonsini in its newly published 2023 edition of IAM Patent 1000 – The World’s Leading Patent Practitioners. The guide recognized the firm with three firm rankings and six Wilson Sonsini attorneys received individual recommendations in the rankings.
Learn More
News Articles
Wilson Sonsini and Attorneys Recognized in 2022 Edition of LMG Life Sciences
LMG Life Sciences recognized several Wilson Sonsini practices and 16 of its attorneys in the 2022 edition of its guide, which identifies and ranks the leading law firms and individuals in the life sciences industry.
Learn More
View All
Recent Events
Speaking Engagements
PTAB Masters™ 2022
Wilson Sonsini is proud to support the PTAB Masters™ 2022 program, presented by IPWatchdog®, and co-chaired by Scott McKeown and Gene Quinn from January 24-27. 2022. PTAB Masters™ 2022 program will focus on the Patent Trial and Appeal Board from the viewpoint of both the patent owner and petitioners challenging patents. From the most important issues facing the PTAB and USPTO as an agency, to discretionary denials and parallel litigation, through PTAB trial tactics and strategies, this program will address the real-world issues facing stakeholders by presenting best practices, expert insights, and master level planning.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Employee Login
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2023 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.